Կանադա -
անգլերեն -
Health Canada
jamp-moxifloxacin tablets
jamp pharma corporation - moxifloxacin (moxifloxacin hydrochloride) - tablet - 400mg - moxifloxacin (moxifloxacin hydrochloride) 400mg - quinolones
Կանադա -
անգլերեն -
Health Canada
jamp-moxifloxacin solution
jamp pharma corporation - moxifloxacin (moxifloxacin hydrochloride) - solution - 0.5% - moxifloxacin (moxifloxacin hydrochloride) 0.5% - antibacterials
Իռլանդիա -
անգլերեն -
HPRA (Health Products Regulatory Authority)
moxifloxacin 400 mg/250 ml solution for infusion, kabipac bottles
fresenius kabi deutschland gmbh - moxifloxacin - solution for infusion - 400/250 milligram(s)/millilitre - fluoroquinolones; moxifloxacin
Իռլանդիա -
անգլերեն -
HPRA (Health Products Regulatory Authority)
moxifloxacin 400 mg/250 ml solution for infusion, freeflex bags
fresenius kabi deutschland gmbh - moxifloxacin - solution for infusion - 400/250 milligram(s)/millilitre - fluoroquinolones; moxifloxacin
Բելգիա -
անգլերեն -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
moxifloxacine eg 400 mg film-coat. tabl.
eg sa-nv - moxifloxacin hydrochloride 436,8 mg - eq. moxifloxacin 400 mg - film-coated tablet - 400 mg - moxifloxacin hydrochloride 436.8 mg - moxifloxacin
Բելգիա -
անգլերեն -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
moxifloxacine fresenius kabi 400 mg/250 ml inf. sol. i.v.
fresenius kabi sa-nv - moxifloxacin hydrochloride 437,5 mg - eq. moxifloxacin 400 mg - solution for infusion - 400 mg/250 ml - moxifloxacin hydrochloride 437.5 mg - moxifloxacin
Բելգիա -
անգլերեն -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
moxifloxacine fresenius kabi 400 mg/250 ml inf. sol. i.v.
fresenius kabi sa-nv - moxifloxacin hydrochloride 437,5 mg - eq. moxifloxacin 400 mg - solution for infusion - 400 mg/250 ml - moxifloxacin hydrochloride 437.5 mg - moxifloxacin
Բելգիա -
անգլերեն -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
moxifloxacine teva 400 mg film-coat. tabl.
teva pharma belgium sa-nv - moxifloxacin 400 mg - film-coated tablet - 400 mg - moxifloxacin 400 mg - moxifloxacin
Ամերիկայի Միացյալ Նահանգներ -
անգլերեն -
NLM (National Library of Medicine)
moxifloxacin- moxifloxacin tablet, film coated
a-s medication solutions - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin tablets are indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3) ]. mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin tablets are indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4) ]. moxifloxacin tablets are indicated in adult patients f
Ամերիկայի Միացյալ Նահանգներ -
անգլերեն -
NLM (National Library of Medicine)
moxifloxacin- moxifloxacin tablet, film coated
a-s medication solutions - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin tablets are indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3) ]. mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin tablets are indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4) ]. moxifloxacin tablets are indicated in adult patients f